• Home
  • Search Results
  • Pharmacological activation of AMPK ameliorates perivascular adipose/endothelial dysfunction in a manner interdependent on AMPK and SIRT1.

Pharmacological activation of AMPK ameliorates perivascular adipose/endothelial dysfunction in a manner interdependent on AMPK and SIRT1.

Pharmacological research (2014-08-12)
Yan Sun, Jia Li, Na Xiao, Meng Wang, Junping Kou, Lianwen Qi, Fang Huang, Baolin Liu, Kang Liu
ABSTRACT

Adipose and endothelial dysfunction is tightly associated with cardiovascular diseases in obesity and insulin resistance. Because perivascular adipose tissue (PVAT) surrounds vessels directly and influences vessel functions through paracrine effect, and AMP-activated protein kinase (AMPK) and sirtuin 1 (SIRT1) show similarities in modulation of metabolic pathway, we hypothesized that activation of AMPK and SIRT1 in PVAT might regulate the endothelial function in pathological settings. Thus, in this study, we focused on the regulation of AMPK and SIRT1 activities implicated in adipocytokine expression and endothelial homeostasis under inflammatory conditions by using salicylate, metformin, AICA riboside (AICAR) and resveratrol as AMPK activating agents. We prepared conditioned medium (CM) by stimulating PVAT with palmitic acid (PA) and observed the effects of AMPK activating agents on adipocytokine expression and vessel vasodilation in rats. Moreover, we explored the effects of resveratrol and metformin in fructose-fed rats. We observed that PA stimulation induced inflammation and dysregulation of adipocytokine expression accompanied with reduced AMPK activity and SIRT1 abundance in PVAT. AMPK activating agents inhibited NF-κB p65 phosphorylation and suppressed gene expression of pro-inflammatory adipocytokines, and upregulated adiponectin and PPARγ expression in PVAT in an AMPK/SIRT1-interdependent manner. Meanwhile, CM stimulation impaired endothelium-dependent vasodilation in response to acetylcholine (ACh). Pretreatment of CM with AMPK-activating agents enhanced eNOS phosphorylation in the aorta and restored the loss of endothelium-dependent vasodilation, whereas this action was abolished by co-treatment with AMPK inhibitor compound C or SIRT1 inhibitor nicotinamide. Long-term fructose-feeding in rats induced dysregulation of adipocytokine expression in PVAT and the loss of endothelium-dependent vasodilation, whereas these alterations were reversed by oral administration of resveratrol and metformin. Altogether, pharmacological activation of AMPK beneficially regulated adipocytokine expression in PVAT and thus ameliorated endothelial dysfunction against inflammatory insult in an AMPK/SIRT1-interdependent manner.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
D-(−)-Fructose, ≥99%
Sigma-Aldrich
Nicotinamide, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Nicotinamide, ≥99.5% (HPLC)
Supelco
Niacinamide, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Fructose, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
AICAR, ≥98% (HPLC), powder
Sigma-Aldrich
Nicotinamide, ≥98% (HPLC), powder
Sigma-Aldrich
D-(−)-Fructose, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Niacinamide, meets USP testing specifications
Sigma-Aldrich
D-(−)-Fructose, BioUltra, ≥99.0% (HPLC)
Supelco
D-(−)-Fructose, analytical standard, analytical standard for fructose assay kit, for use with enzymatic assay kit FA20
Sigma-Aldrich
D-(−)-Fructose, BioXtra
USP
Fructose, United States Pharmacopeia (USP) Reference Standard
Phenylephrine, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Nicotinamide, ≥98.5% (HPLC)
USP
Niacinamide, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
D-(−)-Fructose, meets USP testing specifications
Millipore
D-(−)-Fructose, ≥99.0% (HPLC), suitable for microbiology
Sigma-Aldrich
D-(−)-Fructose, tested according to Ph. Eur.
Nicotinamide, European Pharmacopoeia (EP) Reference Standard
Fructose, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Human ADIPOQ / Adiponectin ELISA Kit, for serum, plasma, cell culture supernatant and urine
Sigma-Aldrich
5-Amino-4-imidazolecarboxamide hydrochloride, 98%
Sigma-Aldrich
Anti-Nitric Oxide Synthase, Endothelial (1185-1205) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-Nitric Oxide Synthase, Endothelial antibody produced in mouse, clone NOS-E1, ascites fluid
Sigma-Aldrich
3-[(1R)-1-Hydroxy-2-(methylamino)ethyl]phenol, AldrichCPR
Sigma-Aldrich
Anti-NOS3 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-NOS3 antibody produced in mouse, clone 1D12, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-NOS3 (Ab-1177) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-NOS3 (Ab-495) antibody produced in rabbit, affinity isolated antibody